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Background: Patients with Lynch Syndrome, the most common hereditary colorectal cancer syndrome, benefit
from genetic education and family counseling regarding diagnostic testing and cancer surveillance/prevention
recommendations. Although genetic counseling is currently the most common venue where such education and
counseling takes place, little is known about the level of disease knowledge and education needs as directly
reported by patients and families with Lynch Syndrome. Furthermore, experiences with forums for larger-scale
knowledge transfer have been limited in the current literature.
Methods: We conducted a one-day interactive multidisciplinary patient conference, designed to complement
individual genetic counseling for updating disease knowledge, supportive networking and needs assessment
among Lynch Syndrome patients and their family members. The patient conference was designed utilizing the
conceptual framework of action research. Paired pre- and post-conference surveys were administered to 44
conference participants anonymously to assess patient-reported disease knowledge and education needs.
Results: A multidisciplinary team of expert providers utilized a variety of educational formats during the one-day
conference. Four main focus areas were: genetic testing, surveillance/prevention, living with Lynch Syndrome, and
update on research. Thirty-two participants (73%) completed the pre-conference, and 28 (64%) participants
completed the post-conference surveys. Nineteen respondents were affected and the remaining were unaffected.
The scores of the disease-knowledge items significantly increased from 84% pre- to 92% post-conference
(p = 0.012). Patients reported a high level of satisfaction and identified further knowledge needs in nutrition (71%),
surveillance/prevention options (71%), support groups (36%), cancer risk assessment (32%), active role in medical
care (32%), and research opportunities (5%).
Conclusion: Our experience with a dedicated patient education conference focused on Lynch Syndrome
demonstrated that such an educational format is effective for updating or reinforcing disease knowledge, for
identifying patient-reported unmet educational needs, as well as for peer-support.
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Lynch Syndrome (LS) is the most common inherited
colorectal cancer (CRC) syndrome. Its hallmarks include
germline defects in the DNA mismatch repair pathway
and microsatellite-high tumor phenotype. Patients are
most commonly predisposed to developing CRC, with
reported lifetime risks ranging from 20-80%. [1,2] They
are also at risk for multiple extra-colonic cancers,
including endometrial, ovarian, gastric, small bowel,
hepato-pancreatic-biliary, genitourinary, sebaceous skin,
and glioblastoma [3-5]. Therefore, early diagnosis, multi-
organ cancer surveillance, and risk-reducing preventive
strategies represent the cornerstones of management
in LS [6,7].
Patients and families benefit from education and
counseling regarding their disease and regarding these
key areas of care [8]. Indeed, lack of patient knowledge
about their disease, cancer risks and treatment options,
has been identified as a significant barrier to adoption
of recommended care [9,10]. Currently, genetic counseling
is the most common platform wherein the counselor
transfers knowledge of the natural history, mode of
transmission, and risks of a genetic disorder to patients
and families. It also represents the main venue for discuss-
ing cancer risk management including recommended
cancer surveillance and risk-reducing strategies, along
with psychosocial support. However, little is known
about the level of disease knowledge and education
needs as directly reported by patients and families with
Lynch Syndrome.
Furthermore, experiences with forums for larger-scale
education regarding Lynch Syndrome have been limited
in the current literature. Genetic counseling is an indi-
vidual communicative process, and the availability and
access to genetic counseling services can be limited
[11,12]. Patients may have ongoing needs for disease edu-
cation, beyond the initial genetic counseling session held
most commonly at the time of initial diagnosis; they may
benefit from reinforcing or updating disease knowledge
and/or management recommendations. Furthermore,
dissemination of genetic information and care recom-
mendations to potentially at-risk family members can
be difficult through the current one-time individual
model of genetic counseling.
We conducted a disease-specific patient-oriented edu-
cation conference to complement individualized genetic
counseling services. The conference aimed to assess pa-
tient needs through interactive feedback, and to allow
larger-scale knowledge transfer to patients and families,
while also assembling patient-based supportive networks.
We herein describe our findings in patient-reported
disease knowledge and education needs, along with our
experience with the organization, delivery, and educational
impact of such a patient conference.Methods
An action research framework for conference
organization and development
In order to ensure the patient-centeredness of the LS
patient conference, a conceptual framework of action
research was adopted to maximize reciprocal interac-
tions throughout the development, design, and delivery
of the conference [13]. Action research is a broad style
of research that has been widely applied in the field of
education. In the teaching context, the goal is to gain
knowledge from students that can lead to new ideas
and strategies and that are then directly help to promote
student success [14]. When adapted to the setting of our
conference, action research represents a cyclical process
of inquiry-and-feedback interactions among organizers
and participants, leading to incorporation of participant
input and informed actions, for the ultimate goal of better
understanding and addressing the needs of patients and
families with LS.
The Clinical Cancer Genetics (CCG) Program at
the University of Texas MD Anderson Cancer Center
(UTMDACC) established a Lynch Syndrome Patient
Education Conference planning committee. The committee
members included two genetic counselors, one behavioral
scientist, and three physicians. The development of this
conference occurred through two cycles of action research
with participant input. During the first cycle, patient
interests and needs as reflected from daily clinical in-
teractions were discussed. Based on these, the target
conference participants were defined, and included both
affected and unaffected probands and family members.
The overall aims of the conference were formulated as: (1)
to directly collect patient-reported experiences, needs, and
feedback related to clinical genetics care; (2) to provide pa-
tients and families with updated knowledge in the clinical
care and research related to LS; (3) to connect patients and
their families with the UTMDACC CCG Program and
other experts in the field; and (4) to empower and connect
patient/families with each other for sharing resources of
support in their communities. During the second action
research cycle, a convenience sample of five patients who
presented for clinic visits was asked about their preferences
and concerns regarding the logistics of the conference such
as timing, location, duration and formats. Institutional
grant funding allowed for free registration, and the confer-
ence location was set to be within car-travel distance of
the institution, coinciding with the 4th Biennal Meeting of
the International Society for Gastrointestinal Hereditary
Tumors (InSIGHT) held in San Antonio, Texas.
Conference content and description
A single-day delivery format, spanning over a total of
6 hours, was chosen based on ease of travel. The edu-
cational format of the conferences included didactic
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moderated round-table breakout sessions, as well as time
for one-on-one question and answers. Didactic content
and conference organization were summarized in Table 1.
Topics covered by the six didactic sessions included:
Historical perspective; Genetic testing; Surveillance;
Psychosocial aspects of living with LS; and Recent/
New research in LS. The lunch hour was utilized for a
set of moderated round-table breakout sessions; each
roundtable addressed a particular topic of interest to
patients (Table 1).
The conference speakers included volunteer patients, as
well as colorectal surgeons (M.A.R-B and Y.N.Y.), behavioral
scientists (S.P.), gastroenterologists (P.M.L.), gynecologic
oncologists (K.L.), genetic counselors (S.A.B.) and invited
experts (Professor Sir John Burn, Professor of Clinical
Genetics, Newcastle University, United Kingdom). All
written materials including speaker slides were organized,
bound and provided to participants free of charge.
Participants
The institutional genetic counseling database was queried
approximately 6 months prior to the anticipated conference
date for potential participants. We included probands and
family members with a defect (either pathogenic mutation
or likely deleterious variant) in any DNA mismatch repair
gene. We also included probands and family members
with non-sporadic microsatellite-high phenotype tumors
(i.e. absence of MLH1 promoter methylation or BRAF-
V600E mutation) in whom either no pathogenic muta-
tion was found on germline testing or recommended
genetic testing had been declined. These target individuals
were mailed save-the-date invitations and a flyer with
preliminary conference agenda 1 and 3 months prior to
the conference. Invitations were extended to all familyTable 1 Summary of the didactic content and organization of
Lynch Syndrome Patient Education Conference
Time Didactic content
Morning 1. Historical perspective of Lynch syndrome
2. Updates in genetic testing
3. Gastrointestinal surveillance strategies
4. Gynecologic surveillance strategies,
5. Living with Lynch syndrome
a) Psychosocial aspects
b) The Genetic Information Non-Discrimination Act (GINA)
c) Patient perspectives of the disease
Lunch Round-table topics included: “I am new to Lynch”; “I am a
survivor”; Healthy lifestyle”; “Genetic testing and GINA”
Afternoon 6. Advances in Lynch syndrome: update on research.
(Emerging chemoprevention trials)
Individualized question & answermembers and were disseminated through the institutional
public website, and other LS-focused organizations and
their corresponding websites such as The Daily Strength
Lynch syndrome group (http://www.dailystrength.org/
groups/lynch-syndrome), The Colon Club (http://www.
colonclub.com), Lynch Syndrome International (http://
lynchcancers.com), and CCARE for Lynch Syndrome
(http://www.fightlynch.org). Participants self-registered for
the Education Conference via the CCG Program public
website. There was no cost for conference registration.
Conference survey
At the time of the conference, all participants were given
a set of paired pre- and post-conference surveys along
with their conference materials. Participants self-selected
to complete these anonymous surveys. A consent form
was attached to the front of the surveys, and participants
acknowledged their voluntary consent by electing to
complete the surveys. The pre-conference survey was
administered and collected prior to the start of the confer-
ence program. Participants were asked not to uncover the
post-conference survey until after the entire conference
program had concluded. The post-conference survey was
completed and collected as participants departed. The
UTMDACC Institutional Review Board granted exempt
status to this study.
The paired pre- and post-conference surveys were
designed a priori. They were pilot tested by two physicians
and a graduate research student who were not involved in
conference planning. The pre-conference survey comprised
35 items. The post-conference survey comprised 31 items
(detailed in Table 2). Twenty minutes were allotted to each
survey. The pre-conference survey assessed demographic
and health characteristics; personal experience with LS










Round-table breakout sessions with




Free format All speakers
Table 2 The University of Texas MD Anderson Cancer Center Lynch Syndrome Patient Education Conference patient survey
Question domains Pre-conference survey Post-conference survey
1. Respondent demographics 7 items (Multiple-choice) 0 item
● Age at LS diagnosis
● Demographics: age, gender, race/ethnicity
● Marital status, educational background, and health
insurance status
● Method of diagnosis
2. Patient-reported experiences with LS 13 items (Multiple-choice) 0 item
● Personal history of cancers diagnoses
● Personal history of surgical interventions
● Surveillance for LS-related cancers
● Sources of knowledge regarding LS
3. Disease knowledge 12 items (Multiple-choice) 12 items (Multiple-choice)
● Hereditary basis of LS ● Hereditary basis of LS
● Transmission pattern ● Transmission pattern
● Risks of LS-related cancers ● Risks of LS-related cancers
● Surveillance strategies ● Surveillance strategies
● Prophylactic options ● Prophylactic options
4. Patient needs assessment and feedback 0 item 19 items (Rating, multiple-choice, free text)
● Learning needs addressed by the conference
● Patient-reported further learning needs
● Feedback regarding conference
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12 knowledge assessment items covering different aspects
of LS relevant to the conference didactic sessions. All
items on the pre-conference survey were of the multiple-
choice format; the 12 items were scored from 0-100%,
with higher percent score indicating a greater proportion
of correct answers. The post-conference survey contained
the 12 knowledge assessment items again, but their order
was reorganized to minimize test/re-test bias. We also
assessed patient-reported knowledge needs; participants
were asked to indicate which health topics they felt
needed more knowledge. Participants were also asked
open-ended questions regarding educational needs that
were most adequately addressed by the conference as
well as any other unaddressed educational needs.
Data analysis
Descriptive statistics were used to summarize survey items
addressing demographics, experience with LS, and per-
ceived value of the conference. All continuous variables
were described by mean and standard deviation (SD),
while all categorical variables, by number and percentage.
Gender-specific items were summarized according to
self-reported gender information. Twelve survey items
examining disease-specific knowledge were compared
between pre- and post-conference surveys using pairedt-test. All statistical tests were two-sided and statistical
significance was denoted by p-value <0.05. All analyses were
performed using STATA statistical software (StataCorp.
2007. Stata: Release 10. College Station, TX).
Results
Forty-four individuals attended the conference. Thirty-
two (73%) completed the pre-conference survey and
28 (64%) participants completed the post-conference
survey.
Demographics (Pre-conference survey, n = 32)
The majority of the respondents was female, white,
educated, married, and had health insurance (Table 3).
Nineteen (59%) respondents reported a personal diag-
nosis of LS. The remaining respondents were family
members without LS (Table 3).
Patient-reported experience with LS (Pre-conference survey,
n = 19 with LS)
Among the 19 respondents with LS, 12 (63%) were female
and the mean age at LS diagnosis was 47 years (SD: 8 years;
range: 22–71). Diagnosis was based on presence of patho-
genic mutation in 14 (74%), non-sporadic microsatellite-
high tumor phenotype in 4 (21%), and pedigree criteria
in 1 (5%).
Table 3 Demographic characteristics of the 32
participants who returned the pre-conference survey
Characteristic Number of patients (% )








Vocational/Some college 1 (3)
High school 9 (28)
Marital status
Married 26 (82)




Not insured 0 (0)
LS Status
Personal history of LS 19 (59)
Family history of LS 13 (41)
FDR with LS 3
Other relative with LS 1
Non-blood relative with LS 4
FDR = first degree relative.
LS = Lynch syndrome.
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tory of colorectal polyps (68%) or cancer (53%), followed
by small bowel polyps (5%) or cancer (5%), and sebaceous
skin neoplasm (5%). Among 12 women with LS, 5 (42%)
had endometrial cancer and one (8%) ovarian cancer.
Eight (42%) of the 19 LS patients had undergone colo-
rectal surgery, and 11 (92%) of the 12 female LS patients
had gynecologic surgery.
Regarding multi-organ cancer surveillance, 18 (95%)
reported undergoing colonoscopy, and the frequency
was every 1–2 years in 11 patients, every 3 years in one,
and unspecified in the remaining. Upper gastrointestinal
endoscopic surveillance was reported by 13 (68%) at a
frequency of at least every 1–2 years in 8 patients, and
unspecified in the remaining. Surveillance of urinary tract
cancers by urinalysis was reported by 10 (53%), and the
frequency was annual in 6 patients. Among women with
LS, 9 (90%) reported endometrial surveillance at least
every two years while their uterus were in place.
Respondents indicated that their main source of know-
ledge regarding LS came from the internet (57%), theirhealth care providers (45%), written materials (30%) and
medical journals (25%). Among healthcare providers, they
indicated genetic counselors (54%) as the main source of
information, followed by gastroenterologists (23%) and/or
surgeons (11%).
Disease knowledge (Paired pre- and post-conference
survey, n = 28)
Twenty-eight paired pre- and post-conference surveys
were compared for scores from the 12 disease knowledge
questions (Table 4). The mean knowledge scores improved
from 84.2 (SD: 9.6) pre-conference to 91.7 (SD:6.7)
post-conference (p = 0.012). For each of the questions,
the proportion of patients who answered the particular
question correctly increased from pre- to post-conference:
the median increase among all questions was 7.4%
(SD: 7.4%; p = 0.025; Table 4). The single item with the
greatest improvement was regarding the use of tumor
molecular testing to screen for patients with Lynch
syndrome (question 10).
Participant-reported learning needs and feedback
(Post-conference survey, n = 28)
Respondents indicated that the conference was the most
helpful in fulfilling their learning needs through: “speaking
with providers/experts”, “networking with other families
with LS”, and “receiving a book of the presentation slides
for future reference”.
The most commonly indicated areas of additional learn-
ing needs and questions included: nutrition and impact on
disease (71%), surveillance and prevention options (71%),
support groups (36%), risk for developing certain types
of cancers/my family’s risk for developing cancer (32%),
active role in planning my medical care (32%) and research
opportunities (5%; Figure 1).
A high level of satisfaction was reported by respondents
who indicated strong agreement with the following state-
ments: “I learned a lot of useful information about Lynch
syndrome today” (28 respondents, 100%); “I plan to use in-
formation I learned today when making decisions about my
healthcare” (27, 96%); “I would recommend this conference
to others” (27, 96%); “I feel the conference was the right
length” (27, 96%); and “I would attend this conference again
if updated information were provided” (26, 93%).
Discussion
Patients with hereditary cancer syndromes such as LS
benefit from cancer risk assessment, disease knowledge,
and cancer surveillance and prevention. Currently, these
tasks are most commonly accomplished through one or
more individualized genetic counseling sessions. Patient-
reported disease knowledge and educational needs have
not been directly reported in the literature. Furthermore,
potential unmet needs in LS may include addressing
Table 4 Proportions of patients answering correctly to each of the twelve disease knowledge questions from pre- to
post-conference surveys







1 Lynch syndrome can be passed to a child through the mother or the father 28 (100) 28 (100) 0.0
2 Within a family, Lynch syndrome can affect each family member differently 26 (93) 28 (100) 7.1
3 Colorectal cancer is the only type of cancer that happens more often
in people with Lynch syndrome
24 (86) 23 (82) −3.6
4 If you look like your parent who has Lynch syndrome, you are more likely
to have Lynch syndrome yourself
21 (75) 24 (86) 10.7
5 If a parent has Lynch syndrome, each child will have a 1 in 4 (or 25%)
chance of having Lynch syndrome
20 (71) 23 (82) 10.7
6 On average, people with Lynch syndrome have a 60-80% chance of
developing cancer of the colon or rectum
23 (82) 26 (93) 10.7
7 People with Lynch syndrome should have a scope exam of their colon
or rectum every 1–2 years
26 (93) 28 (100) 7.1
8 If a person with Lynch syndrome has his/her entire colon surgically
removed, he/she no longer needs continued surveillance or evaluation
of the remaining rectum or pouch
25 (89) 27 (96) 7.1
9 Women with Lynch syndrome have up to a 60% chance to develop
uterine/endometrial cancer
25 (89) 26 (93) 3.6
10 Tests performed on the colon or uterine tumor tissues can be used
to help diagnose Lynch syndrome
19 (68) 26 (93) 25.0
11 Currently, there is only one gene known to be associated with
Lynch syndrome
22 (79) 25 (89) 10.7
12 There is a blood test available that can often identify the genetic
cause of Lynch syndrome
24 (86) 24 (86) 0.0
Bannon et al. Hereditary Cancer in Clinical Practice 2014, 12:1 Page 6 of 8
http://www.hccpjournal.com/content/12/1/1knowledge needs of family members, continued updating
of disease knowledge over time, assessing patient needs
and feedback in aggregate form, as well as opportunity for
group support and networking. Yet experience with edu-
cational formats beyond individual genetic counseling has
not been widely published. We adopted the conceptual
framework of action research and delivered a patient
education conference for LS, borrowing experiencesFigure 1 Education needs as reported by Lynch
syndrome patients.from similar conferences for patients with hereditary
breast and ovarian cancer syndromes [13]. We found that
such a conference highlighted current disease knowledge
and unmet educational needs, allowed effective large-scale
knowledge transfer, and was associated with a high level of
patient satisfaction. These reported findings will hopefully
encourage organization of similar conferences in the future
and stimulate further research regarding optimal ways for
health education in patients with LS.
One goal of our disease-focused patient education con-
ference was to directly collect patient-reported experi-
ences, needs, and feedback, while also providing patients
and families with updated knowledge in the clinical care
and research related to LS. While patient conferences with
similar goals have been reported in the HBOC population
[13], to our knowledge, there has been no formal report of
such conference for LS. We found that patients and family
members attending our conference possessed a relatively
high level of disease knowledge at the onset. Despite this,
a focused day-long conference offering multi-faceted edu-
cation through multiple formats still led to a significant
improvement in disease-specific knowledge beyond the
baseline level. Importantly, our patients identified health-
care providers, and in particular, genetic counselors, as an
important source of their knowledge about their disease.
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vide additional educational benefit from patient conference
that is built on the foundation of prior individual genetic
counseling. The conference serves to update and reinforce,
but not replace, genetic counseling as an effective avenue
for patients to learn about their hereditary syndrome.
Through direct solicitation, we have also documented
learner-reported educational needs and topics of particu-
lar interest to patients and families with LS. Areas of
learning needs included: nutrition and its impact on
disease, options for cancer surveillance and prevention,
support groups, and how to take a more active role in
medical care. Eliciting participant feedback in these areas
of need greatly informs future research, as these are the
target areas for information in both future conferences
and in future individual counseling sessions. These can
also form contents of patient education pamphlets,
educational websites, and/or other education venues,
particularly in the view of the fact that patients identified
the Internet as the most common source of information
related to their disease.
In addition to education, the patient conference was
designed to allow for maximal and efficient interactions
among a multidisciplinary team of providers and patients/
families, among patients and members of their own
families, and among all individuals and families affected
by the same disease. Interactive opportunities included
volunteer patient panels, breakout round tables, question-
and-answer sessions, as well as free times. By having
providers interact with groups of patients, rather than
one-on-one, the discussions triggered by individual
concerns could become educational to and shared with
the whole group, thereby improving educational efficiency.
Additionally, by gathering healthcare providers with diverse
expertise together, patient questions and concerns could be
addressed by the most suitable and experienced provider
while still allowing input from other providers and patients.
Most importantly, for patients with rare syndromes
such as LS, enabling peer-support and networking among
affected families fosters the building of a supportive
community. Based on patient-reported experiences with
LS recorded herein, variations existed among the types
of cancers experienced by the respondents, whether pa-
tients had undergone surgical procedures, and among the
various surveillance practices. This rich mixture of experi-
ences provides the raw material for patient-patient interac-
tions and exchanges. A sense of collective community often
helps to provide psychological support to patients with rare
hereditary syndromes such as LS, as reflected by the growth
and success of institutional/national registries and support
groups such as Lynch Syndrome International. Indeed,
more than a third of the respondents identified support
groups as an unmet need in their care. The conference
format can serve as a springboard for formation ofsuch groups. With increasing use of social media and
internet-based communications, virtual forms of such
conferences might be developed in the future.
We have reported an early and single-institutional
experience with patient education in LS, and our report
is limited in several ways. Our participants represent a
clinic-based population from a single geographic region
with unique demographic characteristics (Table 3), thus
limiting the generalizability of our experience and find-
ings. Secondly, respondent’s knowledge regarding LS
was assessed by short-term recall only. Long-term follow-
up data would be needed to assess knowledge retention
or knowledge-based changes in health-related behavior.
Thirdly, because the surveys were anonymous, we could
not assess for responder vs. non-responder bias.
In conclusion, an interactive multidisciplinary patient
conference provided an opportunity for direct assessment
of patient-reported knowledge and education needs in LS.
This reported experience contributes to the larger effort
to provide comprehensive care to patients with hereditary
cancer syndromes. Further research is needed to examine
the long-term impact of such an educational model in
terms of knowledge retention, guideline adoption, and
translation into improved patient outcomes.
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